115 related articles for article (PubMed ID: 16567829)
1. Polymorphisms of the protein kinase C-beta gene (PRKCB1) accelerate kidney disease in type 2 diabetes without overt proteinuria.
Araki S; Haneda M; Sugimoto T; Isono M; Isshiki K; Kashiwagi A; Koya D
Diabetes Care; 2006 Apr; 29(4):864-8. PubMed ID: 16567829
[TBL] [Abstract][Full Text] [Related]
2. Identification of a common risk haplotype for diabetic nephropathy at the protein kinase C-beta1 (PRKCB1) gene locus.
Araki S; Ng DP; Krolewski B; Wyrwicz L; Rogus JJ; Canani L; Makita Y; Haneda M; Warram JH; Krolewski AS
J Am Soc Nephrol; 2003 Aug; 14(8):2015-24. PubMed ID: 12874455
[TBL] [Abstract][Full Text] [Related]
3. Genetic variants of the protein kinase C-beta 1 gene and development of end-stage renal disease in patients with type 2 diabetes.
Ma RC; Tam CH; Wang Y; Luk AO; Hu C; Yang X; Lam V; Chan AW; Ho JS; Chow CC; Tong PC; Jia W; Ng MC; So WY; Chan JC
JAMA; 2010 Aug; 304(8):881-9. PubMed ID: 20736472
[TBL] [Abstract][Full Text] [Related]
4. No support for association of protein kinase C, beta 1 (PRKCB1) gene promoter polymorphisms c.-1504C>T and c.-546C>G with diabetic nephropathy in Type 1 diabetes.
Pettigrew KA; McKnight AJ; Martin RJ; Patterson CC; Kilner J; Sadlier D; Maxwell AP; Savage DA;
Diabet Med; 2008 Sep; 25(9):1127-9. PubMed ID: 18937679
[No Abstract] [Full Text] [Related]
5. APOE polymorphism and the progression of diabetic nephropathy in Japanese subjects with type 2 diabetes: results of a prospective observational follow-up study.
Araki S; Koya D; Makiishi T; Sugimoto T; Isono M; Kikkawa R; Kashiwagi A; Haneda M
Diabetes Care; 2003 Aug; 26(8):2416-20. PubMed ID: 12882872
[TBL] [Abstract][Full Text] [Related]
6. Association of myeloperoxidase G-463A gene polymorphism with diabetic nephropathy in Japanese type 2 diabetic subjects.
Katakami N; Kume S; Kaneto H; Uzu T; Kashiwagi A; Yamasaki Y; Maegawa H; Shimomura I
Endocr J; 2013; 60(4):457-71. PubMed ID: 23268804
[TBL] [Abstract][Full Text] [Related]
7. Risk of advanced diabetic nephropathy in type 1 diabetes is associated with endothelial nitric oxide synthase gene polymorphism.
Zanchi A; Moczulski DK; Hanna LS; Wantman M; Warram JH; Krolewski AS
Kidney Int; 2000 Feb; 57(2):405-13. PubMed ID: 10652017
[TBL] [Abstract][Full Text] [Related]
8. Protein kinase C beta (PRKCB1) and pigment epithelium derived factor (PEDF) gene polymorphisms and diabetic retinopathy in a south Indian cohort.
Uthra S; Raman R; Mukesh BN; Rajkumar SA; Kumari PR; Lakshmipathy P; Gnanamoorthy P; Sharma T; McCarty CA; Kumaramanickavel G
Ophthalmic Genet; 2010 Mar; 31(1):18-23. PubMed ID: 20141354
[TBL] [Abstract][Full Text] [Related]
9. Dinucleotide repeat polymorphism of matrix metalloproteinase-9 gene is associated with diabetic nephropathy.
Maeda S; Haneda M; Guo B; Koya D; Hayashi K; Sugimoto T; Isshiki K; Yasuda H; Kashiwagi A; Kikkawa R
Kidney Int; 2001 Oct; 60(4):1428-34. PubMed ID: 11576356
[TBL] [Abstract][Full Text] [Related]
10. Clinical and pathological predictors of estimated GFR decline in patients with type 2 diabetes and overt proteinuric diabetic nephropathy.
Mise K; Hoshino J; Ueno T; Hazue R; Sumida K; Hiramatsu R; Hasegawa E; Yamanouchi M; Hayami N; Suwabe T; Sawa N; Fujii T; Hara S; Ohashi K; Takaichi K; Ubara Y
Diabetes Metab Res Rev; 2015 Sep; 31(6):572-81. PubMed ID: 25533683
[TBL] [Abstract][Full Text] [Related]
11. Heat-shock protein gene polymorphisms and the risk of nephropathy in patients with Type 2 diabetes.
Buraczynska M; Swatowski A; Buraczynska K; Dragan M; Ksiazek A
Clin Sci (Lond); 2009 Jan; 116(1):81-6. PubMed ID: 18518860
[TBL] [Abstract][Full Text] [Related]
12. Nonalbumin proteinuria is a simple and practical predictor of the progression of early-stage type 2 diabetic nephropathy.
Kim JH; Kim SS; Kim IJ; Lee MJ; Jeon YK; Kim BH; Song SH; Kim YK
J Diabetes Complications; 2017 Feb; 31(2):395-399. PubMed ID: 27913013
[TBL] [Abstract][Full Text] [Related]
13. Genetic variation at the SLC12A3 locus is unlikely to explain risk for advanced diabetic nephropathy in Caucasians with type 2 diabetes.
Ng DP; Nurbaya S; Choo S; Koh D; Chia KS; Krolewski AS
Nephrol Dial Transplant; 2008 Jul; 23(7):2260-4. PubMed ID: 18263927
[TBL] [Abstract][Full Text] [Related]
14. Course of renal function in type 2 diabetic patients with abnormalities of albumin excretion rate.
Nosadini R; Velussi M; Brocco E; Bruseghin M; Abaterusso C; Saller A; Dalla Vestra M; Carraro A; Bortoloso E; Sambataro M; Barzon I; Frigato F; Muollo B; Chiesura-Corona M; Pacini G; Baggio B; Piarulli F; Sfriso A; Fioretto P
Diabetes; 2000 Mar; 49(3):476-84. PubMed ID: 10868971
[TBL] [Abstract][Full Text] [Related]
15. Predictive impact of elevated serum level of IL-18 for early renal dysfunction in type 2 diabetes: an observational follow-up study.
Araki S; Haneda M; Koya D; Sugimoto T; Isshiki K; Chin-Kanasaki M; Uzu T; Kashiwagi A
Diabetologia; 2007 Apr; 50(4):867-73. PubMed ID: 17225121
[TBL] [Abstract][Full Text] [Related]
16. The influence of a single nucleotide polymorphism within CNDP1 on susceptibility to diabetic nephropathy in Japanese women with type 2 diabetes.
Kurashige M; Imamura M; Araki S; Suzuki D; Babazono T; Uzu T; Umezono T; Toyoda M; Kawai K; Imanishi M; Hanaoka K; Maegawa H; Uchigata Y; Hosoya T; Maeda S
PLoS One; 2013; 8(1):e54064. PubMed ID: 23342076
[TBL] [Abstract][Full Text] [Related]
17. Pentoxifylline for renoprotection in diabetic nephropathy: the PREDIAN study. Rationale and basal results.
Navarro-González JF; Muros M; Mora-Fernández C; Herrera H; Meneses B; García J
J Diabetes Complications; 2011; 25(5):314-9. PubMed ID: 21144773
[TBL] [Abstract][Full Text] [Related]
18. RANTES promoter genotype is associated with diabetic nephropathy in type 2 diabetic subjects.
Nakajima K; Tanaka Y; Nomiyama T; Ogihara T; Ikeda F; Kanno R; Iwashita N; Sakai K; Watada H; Onuma T; Kawamori R
Diabetes Care; 2003 Mar; 26(3):892-8. PubMed ID: 12610055
[TBL] [Abstract][Full Text] [Related]
19. A single nucleotide polymorphism within the acetyl-coenzyme A carboxylase beta gene is associated with proteinuria in patients with type 2 diabetes.
Maeda S; Kobayashi MA; Araki S; Babazono T; Freedman BI; Bostrom MA; Cooke JN; Toyoda M; Umezono T; Tarnow L; Hansen T; Gaede P; Jorsal A; Ng DP; Ikeda M; Yanagimoto T; Tsunoda T; Unoki H; Kawai K; Imanishi M; Suzuki D; Shin HD; Park KS; Kashiwagi A; Iwamoto Y; Kaku K; Kawamori R; Parving HH; Bowden DW; Pedersen O; Nakamura Y
PLoS Genet; 2010 Feb; 6(2):e1000842. PubMed ID: 20168990
[TBL] [Abstract][Full Text] [Related]
20. Identification of specific angiotensin-converting enzyme variants and haplotypes that confer risk and protection against type 2 diabetic nephropathy.
Ezzidi I; Mtiraoui N; Kacem M; Chaieb M; Mahjoub T; Almawi WY
Diabetes Metab Res Rev; 2009 Nov; 25(8):717-24. PubMed ID: 19787680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
